Coldstream Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.14M | Buy |
5,507
+714
| +15% | +$278K | 0.04% | 266 |
|
2025
Q1 | $2.08M | Buy |
4,793
+876
| +22% | +$381K | 0.04% | 239 |
|
2024
Q4 | $1.44M | Sell |
3,917
-269
| -6% | -$99.2K | 0.03% | 305 |
|
2024
Q3 | $2.13M | Buy |
4,186
+490
| +13% | +$250K | 0.05% | 224 |
|
2024
Q2 | $2M | Buy |
3,696
+53
| +1% | +$28.7K | 0.05% | 204 |
|
2024
Q1 | $1.89M | Buy |
3,643
+172
| +5% | +$89.2K | 0.05% | 210 |
|
2023
Q4 | $1.64M | Buy |
3,471
+23
| +0.7% | +$10.8K | 0.05% | 211 |
|
2023
Q3 | $1.5M | Sell |
3,448
-106
| -3% | -$46.2K | 0.05% | 212 |
|
2023
Q2 | $1.58M | Sell |
3,554
-177
| -5% | -$78.7K | 0.05% | 210 |
|
2023
Q1 | $1.72M | Sell |
3,731
-116
| -3% | -$53.3K | 0.06% | 199 |
|
2022
Q4 | $1.97M | Buy |
+3,847
| New | +$1.97M | 0.07% | 173 |
|
2022
Q2 | $1.73M | Buy |
3,583
+567
| +19% | +$274K | 0.07% | 158 |
|
2022
Q1 | $1.48M | Sell |
3,016
-195
| -6% | -$95.8K | 0.05% | 197 |
|
2021
Q4 | $1.49M | Buy |
3,211
+1,984
| +162% | +$920K | 0.05% | 203 |
|
2021
Q3 | $330K | Sell |
1,227
-231
| -16% | -$62.1K | 0.02% | 299 |
|
2021
Q2 | $557K | Buy |
1,458
+32
| +2% | +$12.2K | 0.02% | 260 |
|
2021
Q1 | $512K | Buy |
1,426
+129
| +10% | +$46.3K | 0.03% | 219 |
|
2020
Q4 | $417K | Buy |
1,297
+313
| +32% | +$101K | 0.03% | 234 |
|
2020
Q3 | $265K | Buy |
984
+118
| +14% | +$31.8K | 0.02% | 256 |
|
2020
Q2 | $228K | Buy |
+866
| New | +$228K | 0.02% | 268 |
|
2020
Q1 | – | Sell |
-876
| Closed | -$265K | – | 301 |
|
2019
Q4 | $265K | Sell |
876
-69
| -7% | -$20.9K | 0.02% | 275 |
|
2019
Q3 | $226K | Sell |
945
-84
| -8% | -$20.1K | 0.02% | 291 |
|
2019
Q2 | $290K | Sell |
1,029
-39
| -4% | -$11K | 0.02% | 251 |
|
2019
Q1 | $307K | Buy |
1,068
+112
| +12% | +$32.2K | 0.03% | 235 |
|
2018
Q4 | $251K | Buy |
+956
| New | +$251K | 0.02% | 259 |
|